REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioalpha Holdings Berhad (Malaysia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bioalpha Holdings Berhad Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bioalpha Holdings Berhad is an investment holding company that manufactures and sells semi-finished and finished health supplement products in Malaysia. Bioalpha offers raw materials comprising Cordyceps Sinensis Mycelium powder, Linosus Rhinocerus Mycelium powder, and various medicinal herbs. Bioalpha is listed on Bursa Malaysia. The company was founded in 2011 and based in Kuala Lumpur, Malaysia.

Headquarters
No. 1, Jalan Perindustrian Suntrack, Hub Suntrack Industrial, Off Jalan P1A, Seksyen 13, Bandar Baru Bangi
Kajang; Selangor; Postal Code: 43000

Contact Details: Purchase the Bioalpha Holdings Berhad report to view the information.

Website: http://www.bioa.net

Basic Information
Total Employees:
Purchase the Bioalpha Holdings Berhad report to view the information.
Outstanding Shares:
Purchase the Bioalpha Holdings Berhad report to view the information.
Financial Auditors:
Purchase the Bioalpha Holdings Berhad report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
5.075%
Subsidiaries
Bioalpha (Hk) Limited (Hong Kong SAR, China)
100%
Lkl International Berhad
Company Performance
Financial values in the chart are available after Bioalpha Holdings Berhad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
28.74%
Total operating revenue
39.55%
Operating profit (EBIT)
39.35%
EBITDA
58.32%
Net Profit (Loss) for the Period
17.84%
Total assets
-14.77%
Total equity
-20.41%
Operating Profit Margin (ROS)
54.85%
Net Profit Margin
49.31%
Return on Equity (ROE)
-0.94%
Debt to Equity Ratio
3.53%
Quick Ratio
-2.89%
Cash Ratio
-1.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?